Quick Answer
RESMED INC reported Total Revenue of $5.15 billion for the year ending 2025.
- RESMED INC showed an increase of +9.8% in Total Revenue from 2024 to 2025.
- This data is from RESMED INC's annual report (Form 10-K), filed with the SEC on August 8, 2025.
- XBRL data for this metric is available from 2017 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2017: $523.66 million | Q4 2017: $601.27 million | Q1 2018: $591.63 million | Q3 2018: $588.28 million | Q4 2018: $651.10 million | Q1 2019: $662.23 million | Q3 2019: $681.06 million | Q3 2019: $681.06 million | Q4 2019: $736.16 million | Q4 2019: $736.16 million | Q1 2020: $769.46 million | Q1 2020: $769.46 million | Q3 2020: $751.94 million | Q4 2020: $800.01 million | Q1 2021: $768.77 million | Q3 2021: $904.02 million | Q4 2021: $894.87 million | Q1 2022: $864.50 million | Q3 2022: $950.29 million | Q4 2022: $1.03 billion | Q1 2023: $1.12 billion | Q3 2023: $1.10 billion | Q4 2023: $1.16 billion | Q1 2024: $1.20 billion | Q3 2024: $1.22 billion | Q4 2024: $1.28 billion | Q1 2025: $1.29 billion | Q3 2025: $1.34 billion | Q4 2025: $1.42 billion.
- Over the full 11 years of available data (2017 to 2025), RESMED INC's Total Revenue has grown by 149.0%.
- Historical annual values: Fiscal year 2025: $5.15 billion | Fiscal year 2024: $4.69 billion | Fiscal year 2023: $4.22 billion | Fiscal year 2022: $3.58 billion | Fiscal year 2021: $3.20 billion | Fiscal year 2020: $2.96 billion | Fiscal year 2020: $2.96 billion | Fiscal year 2019: $2.61 billion | Fiscal year 2019: $2.61 billion | Fiscal year 2018: $2.34 billion | Fiscal year 2017: $2.07 billion.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: